STRATA Skin Valuation
| SSKN Stock | USD 2.94 0.11 3.61% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. STRATA Skin Sciences has a current Real Value of $3.2 per share. The regular price of the company is $2.94. Our model measures the value of STRATA Skin Sciences from evaluating the company fundamentals such as shares outstanding of 4.17 M, and Return On Equity of -0.63 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting STRATA Skin's valuation include:
Price Book 1.3617 | Enterprise Value 22.1 M | Enterprise Value Ebitda -7 K | Price Sales 0.3887 | Enterprise Value Revenue 0.6775 |
Undervalued
Today
Please note that STRATA Skin's price fluctuation is unstable at this time. Calculation of the real value of STRATA Skin Sciences is based on 3 months time horizon. Increasing STRATA Skin's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since STRATA Skin is currently traded on the exchange, buyers and sellers on that exchange determine the market value of STRATA Stock. However, STRATA Skin's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.94 | Real 3.2 | Target 3.9 | Hype 2.94 | Naive 2.98 |
The intrinsic value of STRATA Skin's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence STRATA Skin's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of STRATA Skin Sciences helps investors to forecast how STRATA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of STRATA Skin more accurately as focusing exclusively on STRATA Skin's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use STRATA Skin's intrinsic value based on its ongoing forecasts of STRATA Skin's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against STRATA Skin's closest peers.
STRATA Skin Cash |
|
STRATA Valuation Trend
Knowing STRATA Skin's actual value is paramount for traders when making sound investment determinations. Using both STRATA Skin's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
STRATA Revenue by Product
STRATA Skin Total Value Analysis
STRATA Skin Sciences is at this time forecasted to have valuation of 22.14 M with market capitalization of 12.72 M, debt of 15.63 M, and cash on hands of 10.04 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the STRATA Skin fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
22.14 M | 12.72 M | 15.63 M | 10.04 M |
STRATA Skin Investor Information
About 60.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.36. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. STRATA Skin Sciences recorded a loss per share of 2.6. The entity last dividend was issued on the 7th of April 2017. The firm had 1:10 split on the 7th of June 2024. Based on the analysis of STRATA Skin's profitability, liquidity, and operating efficiency, STRATA Skin Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.STRATA Skin Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. STRATA Skin has an asset utilization ratio of 79.39 percent. This suggests that the Company is making $0.79 for each dollar of assets. An increasing asset utilization means that STRATA Skin Sciences is more efficient with each dollar of assets it utilizes for everyday operations.STRATA Skin Ownership Allocation
The market capitalization of STRATA Skin is $12.72 Million. Over half of STRATA Skin's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.STRATA Skin Profitability Analysis
The company reported the previous year's revenue of 33.36 M. Net Loss for the year was (10.83 M) with profit before overhead, payroll, taxes, and interest of 19.85 M.About STRATA Skin Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of STRATA Skin Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of STRATA Skin Sciences based exclusively on its fundamental and basic technical indicators. By analyzing STRATA Skin's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of STRATA Skin's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of STRATA Skin. We calculate exposure to STRATA Skin's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of STRATA Skin's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 18.5 M | 11.1 M | |
| Pretax Profit Margin | (0.33) | (0.34) | |
| Operating Profit Margin | (0.26) | (0.27) | |
| Net Loss | (0.32) | (0.34) | |
| Gross Profit Margin | 0.55 | 0.58 |
STRATA Skin Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 3.5 M |
STRATA Skin Current Valuation Indicators
STRATA Skin's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final STRATA Skin's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as STRATA Skin, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use STRATA Skin's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes STRATA Skin's worth.When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.60) | Revenue Per Share 9.347 | Quarterly Revenue Growth 0.022 | Return On Assets (0.07) | Return On Equity (0.63) |
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.